One or more brief periods of ischemia, termed preconditioning, dramatically limits infarct size and reduces intracellular acidosis during subsequent ischemia, potentially via enhanced sarcolemmal proton efflux mechanisms. To test the hypothesis that preconditioning increases the functional activity of sodium-dependent proton efflux pathways, isolated rat hearts were subjected to 30 min of global ischemia with or without preconditioning. Intracellular sodium (Nai) was assessed using 23Na magnetic resonance spectroscopy, and the activity of the Na-H exchanger and Na-K-2CI cotransporter was measured by transiently exposing the hearts to an acid load (NH4CI washout). Creatine kinase release was reduced by greater than 60% in the preconditioned hearts (P < 0.05) and was associated with improved functional recovery on reperfusion. Preconditioning increased Na1 by 6.24+2.04 U, resulting in a significantly higher level of Na1 before ischemia than in the control hearts. Na, increased significantly at the onset of ischemia (8.48+1.21 vs. 2.57±0.81 U, preconditioned vs. control hearts; P < 0.01). Preconditioning did not reduce Na, accumulation during ischemia, but the decline in Na; during the first 5 min of reperfusion was significantly greater in the preconditioned than in the control hearts (13.48±+1.73 vs. 2.54+0.41 U; P < 0.001). Exposure of preconditioned hearts to ethylisopropylamiloride or bumetanide in the last reperfusion period limited in the increase in Na1 during ischemia and reduced the beneficial effects of preconditioning. After the NH4Cl prepulse, preconditioned hearts acidified significantly more than control hearts and had significantly more rapid recovery of pH (preconditioned, ApH = 0.35+0.04 U over 5 min; control, ApH = 0.15+0.02 U over 5 min). This rapid pH recovery was not affected by inhibition of the Na-K-2Cl cotransporter but was abolished by inhibition of the Na-H exchanger. These results demonstrate that preconditioning alters the kinetics of Na; accumulation during global ischemia as well as proton transport after NH4Cl washout. These observations are consistent with stimulation of the Na-K2Cl cotransporter and Na-H exchanger by preconditioning.
Introduction
Preconditioning is a phenomenon in which one or more brief periods of ischemia protect the myocardium during a subsequent period of ischemia, with the degree of protection classically defined as limitation of infarct size (1) (2) (3) . Preconditioning has been demonstrated in a variety of species, but there are no clearly defined and accepted mechanisms to explain the endogenous cardioprotection of preconditioning. Several theories have been proposed to explain the possible mechanism(s) by which ischemic preconditioning reduces infarct size, including preservation of myocardial high energy stores during ischemia (4) , adenosine receptor stimulation (5), activation of ATP-sensitive K+ channels (6) , and translocation and activation of protein kinase C (7, 8) .
Ischemic preconditioning has been shown, by this group as well as by others, to limit acidosis during global ischemia (4, 9) . Limitation of acidosis could be due to either (a) reduced proton production or (b) enhanced proton efflux. Reduced proton production would reduce the stimulus for increasing sodium entry via the Na-H exchanger and potentially result in lower levels of intracellular sodium (Nai) during ischemia. Enhanced proton efflux, which may occur because of stimulation of the Na-H exchanger, could, conversely, result in an increase in Nai during ischemia. Stimulation of the Na-H exchanger by preconditioning would also alter the response of the heart to acidification resulting from an acid load in the absence of ischemia.
This study tested the hypothesis that ischemic preconditioning stimulates sodium-dependent proton efflux pathways (such as the Na-H exchanger) in the heart, resulting in increased proton efflux and reduced acidosis during subsequent ischemia. This hypothesis was tested using 23Na and 31P nuclear magnetic resonance (NMR)' spectroscopy in preconditioned and control Response to NH4CI pre-pulse
General methods
All experiments were performed with the approval of the University of California, Davis, Animal Research Committee.
Isolated heart model
Experiments were performed using an isovolumic isolated perfused rat heart preparation. Male Sprague-Dawley rats (-350 g) were pretreated with heparin ( 1,000 U intraperitoneally [IP] ), followed by sodium pentobarbital (65 mg/kg IP). After deep anesthesia was achieved as determined by the absence of a foot reflex, the heart was rapidly excised and placed into iced saline. The arrested heart was perfused in a retrograde manner through the aorta within 2 min. The left ventricular developed pressure (LVDP) was determined using a latex balloon in the left ventricle, with high pressure tubing connected to a pressure transducer. Perfusion pressure (PP) was also monitored using high pressure tubing off the perfusion line. Hemodynamic measurements were recorded on a four-channel recorder (Windowgraf; Gould Inc., Valley View, OH). The heart was perfused using an accurate roller pump at a flow rate of 12.5 ml/min (Rainin Instrument Co., Woburn, MA). The perfusate consisted of (in millimoles per liter) NaCl, 118; KCl, 4; CaCl2, 1.2; MgCI2, 1; NaHCO3, 25; with the substrate being 11 mM glucose. The perfusion apparatus was tightly temperature controlled, with heated baths used for the perfusate and for the water jacketing around the perfusion tubing to maintain heart temperature at 37±0.50C under all conditions. Oxygenation of the perfusate was provided by a pediatric hollow fiber oxygenator (Capiax II; Terumo Corp., Tokyo, Japan) immediately proximal to the heart. This preparation has routinely been stable for 3-4 h (10).
Creatine kinase
Creatine kinase (CK) was measured from timed 5-min collections of the effluent for 60 min of reperfusion after the ischemic period. This extended period of collection was employed because preliminary experiments showed that, in control hearts, CK release was maximal after 30 min of reperfusion and was stabilized within 60 min. Each 5-min collection was analyzed in duplicate using established spectrophotomet-( ric methods (11) . Total integrated CK activity over the reperfusion period was calculated for each heart and corrected for dry weight of the heart. CK release was expressed in IU/g dry weight (gdw). As previously shown ( 12) , the integral of the CK release is a representative measure of ischemic injury and infarction.
NMR spectroscopy Phosphorus-31. All NMR spectroscopy was performed on a vertical bore spectrometer (AMX 400; Bruker Instruments Inc., Billerica MA) using a switchable 20-mm probe tuned for 31p or 23Na. 31p NMR spectroscopy was performed using 228 acquisitions of a 60°pulse and a 1.6-s interpulse delay, with spectra processed using an exponential multiplication of 20 Hz and Fourier transformed. Intracellular pH was calculated from the chemical shift between the inorganic phosphate (Pi) and phosphocreatine (PCr) resonance using a titration curve established in this facility ( 13) . Sodium-23. Intracellular sodium content, Nat, was determined using the shift reagent (7 mM Dy (YTHA)3-) added to the standard perfusate throughout the entire experimental period. 23Na spectra were acquired using the broad-band probe tuned to 105.85 MHz. 1,000 free induction decays were signal averaged over 5 min using 90°pulses with a ±4,000-Hz sweep width. 23Na spectra were processed on the Bruker spectrometer. After baseline correction, the extracellular resonance was inverted, shifted, and subtracted from the original spectrum to obtain the intracellular resonance. The area of the intracellular resonance was determined without constraining the line fit to either a Lorentzian or Gaussian shape. These operations were performed in duplicate for each spectrum and the values averaged. The Fig. 1 To determine whether use of the shift reagent had any effects on functional recovery or infarct size, hearts with and without ischemic preconditioning were studied both with and without DyTIHA3-in the perfusate (n = 6 in each group). DyTTHA3-was added to the perfusate after an initial stabilization period. After 40 min of perfusion, control hearts were subject to 30 min of global ischemia followed by 60 min of reperfusion. Preconditioned hearts were subject to four 5-min periods of no-flow ischemia, with each period of ischemia followed by 5 min of reperfusion. As in the control hearts, the preconditioned hearts were then subject to 30 min of global ischemia followed by 60 min of reperfusion.
Response of intracellular sodium to ischemia and reperfusion Control (n = 8) and preconditioned (PC, n = 6) hearts were studied using 23Na NMR. As in the functional measurements, hearts in each group were subjected to 30 min of global ischemia followed by 60 min of reperfusion after 40 min of either control perfusion or four 5-min preconditioning episodes all in the presence of DyTTHA3-. Preconditioned hearts in which EIPA (n = 5) or bumetanide (n = 5) was added to the hearts during the last reperfusion period before global ischemia were also studied using 23Na NMR.
Response to an acid load
To test the hypothesis that preconditioning increases proton efflux, pH recovery was measured in 20 control and preconditioned hearts (n = 4 in each condition) after exposure to an acid load in the three protocols described earlier. In each protocol, hearts were exposed to 20 mM NH4Cl for 10 min in a K+-free buffer that contained 100 JLM ouabain to inhibit Na transport via Na,K-ATPase. After this 10-min exposure to NH4Cl, hearts were perfused for 30 min with K+-free/ouabain buffer not containing NH4Cl. This washout phase decreased pH as the NH4' that had previously entered then dissociated into NH3 + H+ (14) . The ability of the cell to extrude protons was then reflected in the subsequent increase in pH. The first protocol (A) did not contain any membrane transport inhibitors during the NH4Cl exposure or washout other than the K+-free/ouabain buffer. Because preconditioning could affect the Na-K-2Cl cotransporter, which is a potential mechanism for NH4 transport into the cell (15) , the second protocol (B) included 10 ILM bumetanide during NH4Cl exposure and removal to inhibit the Na-K-2Cl cotransporter. The third protocol (C) employed 10 IM EIPA during the NH4Cl washout phase to determine the role of the Na-H exchanger in preconditioned hearts.
Results

Function
Use of the shift reagent Dy(TTHA)3-during 23Na NMR experiments did not alter cardiac function in either the control or preconditioned hearts. LVDP was not different in any group under baseline conditions before global ischemia (84±8 mmHg in the control hearts, 76±7 mmHg in the control hearts with 7 mM Dy(TTHA)3-, 82±8 mmHg in the preconditioned hearts, 79±7 mmHg in the preconditioned hearts with 7 mM Dy(FTHA)3-) and fell to 0 during the first 5 min of global ischemia in all hearts. Similarly, heart rates were identical in all the groups during baseline conditions, and ischemia caused a rapid cessation of cardiac rhythm. Reperfusion of the control hearts resulted in limited functional recovery. LVDP and rhythmic activity did not recover in three hearts, with the average developed pressure only 12±5 mmHg after 60 min of reperfusion in the remaining hearts (P < 0.01 vs. PC). All the preconditioned hearts exhibited significant functional recovery, with LVDP recovering to 48±7 mmHg after 60 min of reperfusion. This degree of functional recovery was similar to that observed in our earlier studies (9) .
Preconditioned hearts treated with EIPA in the last reperfusion period before ischemia had significant diminution of functional recovery compared with preconditioned hearts. Left ventricular developed pressure was 79±8 mmHg before ischemia and 27±7 mmHg (P < 0.05 vs. PC) at the end of reperfusion. Similarly, treatment with bumetanide reduced developed pressure from 78±6 mmHg before ischemia to 16±6 mmHg (P < 0.01) at the end of reperfusion.
Ischemic injury CK release, a measure of myocardial injury and infarction, was significantly reduced after 30 min of global ischemia in the preconditioned hearts and was not affected by DyTTHA (CK release: 1186± 117 IU/gdw in control hearts, 372+63 in the preconditioned hearts, and 414±54 in the preconditioned hearts with 7 mM Dy(TTHA)3-); P < 0.01 preconditioned vs control hearts). These reductions in ischemic injury following preconditioning are similar to those observed in our earlier studies (9 the preconditioned than in the control hearts 5 min before the 30-min ischemia period (P < 0.05). As seen in Fig. 4 , there was a rapid and significant increase in Nai during the first 5 min of the ischemia period in the preconditioned hearts but not in the control hearts, with intracellular Nai increasing 8.48±+1.21 U in the preconditioned hearts compared with 2.57+0.81 U in the control hearts (P < 0.01). The subsequent changes in Na, during ischemia were similar in the preconditioned and control hearts, yielding similar end-ischemia values before reperfusion. Intracellular sodium decreased by 13.48±1.73 U, or 30% of its final ischemia value, in the preconditioned hearts during the first 5 min of reperfusion, compared with a decrease of 2.54+1.24 U, or 6% of its final ischemia value, in the control hearts (P < 0.001). Thus, the response of Nai during ischemia in the preconditioned hearts was characterized by an accelerated increase in Nai at the onset of ischemia and accelerated decrease on reperfusion.
As in the untreated preconditioned hearts, the preconditioned hearts treated with either EIPA or bumetanide during the last reperfusion period before 30 min of global ischemia demonstrated gradual increases in Nai during the preconditioning episodes (8.48+0.48 and 11.94±.9.92 U, respectively; duced compared with that in either control or preconditioned hearts, while the increase in Na1 was not reduced by bumetanide (17.56±1.53 U). The end-ischemia value of Nai in the bumetanide-treated hearts was significantly higher than that in the EIPA-treated hearts (P < 0.05). The decrease in Nai during the first 5 min of reperfusion in the EIPA-and bumetanidetreated hearts was similar to that of control hearts and significantly less than that of preconditioned hearts. All groups had similar values of Na, at the end of reperfusion.
Response to an acid load (NH4Cl prepulse)
The response of control and preconditioned hearts to an acid load is shown in Fig. 6 . Each 5-min preconditioning episode (Na,) time (min) Figure 6 . Changes in intracellular pH as a function of time in control and preconditioned hearts without (control, * and preconditioned (PC), *) and with (control, A and preconditioned, * ) bumetanide added to the perfusate during NH4Cl exposure and washout. The hearts were exposed to NH4Cl for 10 min followed by washout in K+-free buffer containing ouabain as described in Fig. 1 . The data points during NH4Cl exposure (time -5 and 0 min) and during NH4Cl washout (time 5-20 min) are shown here. NH4Cl was removed from the perfusate at the end of the acquisition period marked "NH4 removal." Bumetanide eliminated the greater acidification of the preconditioned hearts, suggesting that greater acidification was due to increased activity of the Na-K-2C1 cotransporter. Rapid pH recovery was maintained in the preconditioned hearts despite the presence of bumetanide and a nadir pH equal to that of control hearts, suggesting that this recovery was independent of the cotransporter. *P < 0.05 PC and PC + bumetanide vs. control and control + bumetanide hearts, respectively. shown Response to an acid load (NH4Cl prepulse) with inhibition of the Na-K-2CI cotransporter. Because the increased acidification observed in the preconditioned hearts could be a result of increased entry of NH4' via the Na-K-2Cl cotransporter (NH4' can substitute for K + on the cotransporter) ( 15 ), further experiments were performed in the presence of 10 uM bumetanide (a potent inhibitor of the Na+-K+-2Cl-cotransporter) (16, 17) . The results, shown in Fig. 6 , demonstrate that bumetanide significantly limited intracellular acidification in both the preconditioned and control hearts although, as in the prior experiments, the preconditioned hearts acidified more than the control hearts and alkalinized more rapidly (ApH = 0.28±0.02 vs. ApH = 0.10±0.03 over 5 min, preconditioned vs. control, respectively; P < 0.001). The lower nadir pH in the preconditioned hearts in the absence of bumetanide suggests greater NH4' entry into the heart via the Na-K-2Cl cotransporter, and therefore that preconditioning stimulated inward flux of the cotransporter.
Despite these differences in nadir pH in the presence or absence of bumetanide, the rate of pH recovery after an ammonium prepulse in the preconditioned hearts was similar in the presence and absence of bumetanide (ApH = 0.28±0.02 in the presence of bumetanide, ApH = 0.35±0.04 in the absence of bumetanide over 5 min; Fig. 6 ), suggesting that the enhanced pH recovery of the preconditioned hearts after an acid load did not involve the Na-K-2C1 cotransporter.
Response to an acid load (NH4CI prepulse) with inhibition of the Na'-H' exchanger. To determine the role of the NaH exchanger in pH recovery after an acid load, experiments similar to those above were performed in which the Na-H exchanger was inhibited by 10 ILM EIPA during the washout phase after an ammonium prepulse ( 18 ) . Fig. 7 demonstrates that 
Discussion
This study has demonstrated that ischemic preconditioning resulted in a rapid increase in Nai at the onset of global ischemia and a rapid decrease on reperfusion, consistent with stimulation of mechanisms that enhance sodium transport across the sarcolemma under these conditions. The response of preconditioned hearts to an acid load under conditions in which the Na-KATPase and Na-K-2C1 cotransporter were inhibited are consistent with preconditioning stimulating the Na-K-2C1 cotransporter (resulting in increased acidosis following a NH4Cl prepulse) and the Na-H exchanger (resulting in more rapid recovery from acidosis). In support of a role for stimulation of these sodium transport mechanisms in the protective effect of preconditioning, inhibition of these changes in sodium transport blunted the protective effects of preconditioning on functional recovery and on ischemic injury. Na+i accumulation in preconditioning. Few studies have measured intracellular sodium during ischemia in preconditioned hearts (19, 20) . In adult rat hearts, Steenbergen et al. (19) used the sodium shift reagent thulium-DOTP5-in combination with the calcium chelator 5F-BAPTA in a protocol similar to the one employed in the current study. They found no significant differences in Nai between control and preconditioned hearts. The current observations of a rapid increase in Na, at the onset of ischemia, no reduction in Nai at the end of ischemia, and a rapid decrease in Na, on reperfusion were not seen by Steenbergen et al. (19) . The failure to demonstrate these kinetic changes in Na+i in their study may have been due to (a) loading of perfused hearts with the calcium chelator 5F-BAPTA, resulting in low developed pressure throughout the experiment; (b) the presence of at least 20 mM NH4 as a counter-cation with their shift reagent (based on the preparation methodology employed); and (c) baseline ischemia preparations, signified by low pre-ischemia PCr/ATP ratios and progressive reductions in pH with the preconditioning episodes before global ischemia. Na transport mechanisms. The observed changes in Nat, and particularly the rapid increase in Nai at the onset of ischemia in the preconditioned hearts, are consistent with stimulation of transport mechanisms that increase sodium entry into the cell. PC+EIPA Na'-H+ exchanger, with stimulation of either potentially resulting in reduced intracellular acidosis during ischemia. Regulation of the Na-K-2C1 cotransporter is multifactorial, with evidence that the cotransporter is regulated by changes in cell volume (15) and cyclic-AMP-dependent (21) (22) (23) and noncAMP-dependent protein phosphorylation (24) as well as ionic concentration gradients. Increased inward cotransporter flux during ischemia after preconditioning could be beneficial in protecting the heart through its functional coupling with the Cl/ HCO3 exchanger (25) . In this paradigm, chloride transported into the cell by the Na-K-2C1 cotransporter may exit via Cl/ HCO3 exchange, thus increasing intracellular HCO3 and limiting acidosis.
The primary factors regulating the Na-H exchanger include the intracellular proton concentration and the phosphorylation state (26, 27) . Under baseline conditions, the exchanger contributes to the extracellular/intracellular proton gradient with net outward transport of protons (28) . Under conditions of ischemia in which protons are generated and intracellular pH decreases, the exchanger is stimulated to increase extrusion of protons, although with an obligatory increase in inward transport of sodium ions (29) . The prior observations of reduced acidification during ischemia (9) and the current observations of an increased rate of intracellular sodium accumulation following preconditioning are consistent with stimulation of either the cotransporter or exchanger by preconditioning. These findings are similar to those observed by Bak and Ingwall (30) in hyperthyroid rat hearts in which increased activity of the Na-H exchanger resulted in higher pH during global ischemia, and may also explain the excellent recovery of function in hypertrophied hearts from hyperthyroid rats after global ischemia (31) .
Reduction in Nai on reperfusion. Despite similar levels of intracellular sodium during ischemia in the preconditioned hearts, there was a significantly more rapid reduction in Nai on reperfusion, presumably reflecting increased sodium efflux. These findings are concordant with the rapid reduction in Nai observed by Tani and Neely (32) in hearts pretreated by 10 min of anoxia before global ischemia (a likely "preconditioning" stimulus). Although previous studies have demonstrated that the cotransporter is directed into the cell under control conditions (33), arguments concerning thermodynamics and previous studies (34, 35) show that the cotransporter may be directed out of the cell during ischemia and reperfusion. Therefore, one potential mechanism that could increase sodium efflux under conditions of high intracellular sodium and chloride at the end of ischemia (36) is outward flux through the Na-K-2Cl cotransporter. A significant role for this mechanism is supported by the acidification of preconditioned hearts after exposure to NH4Cl (as discussed below) and the deleterious effect that bumetanide (a Na-K-2Cl cotransporter inhibitor) had on inhibiting sodium efflux during reperfusion when Na,K-ATPase was inhibited (35) .
Response to an acid load in preconditioning: acidification. The pH response to an acid load using ammonium prepulse experiments is an established measure to differentiate the possible mechanisms involved in proton extrusion and, as used in this study, provides insight into the effect of preconditioning on the Na-K-2C1 cotransporter and Na-H exchanger. Under the conditions of the present experiments (K+-free perfusate containing ouabain), acidification on NH4' removal was likely to be the result of entry of NH4' by the K+ channels or Na-K-2C1 cotransporter. Because the greater reduction in pH after removal of NH4Cl in the preconditioned hearts was eliminated by bumetanide, increased acidification in the preconditioned hearts was likely due to stimulation of the Na-K-2C1 cotransporter. There are several mechanisms by which Na-K-2C1 cotransporter activity could be altered. Opening of ATP-sensitive potassium channels (KATP channels), known to be involved in several models of preconditioning (37) , could increase extracellular K+ and increase inward cotransporter flux (34) . Alternatively, because protein kinase activation has been implicated in preconditioning (8) , direct phosphorylation of the cotransporter could similarly increase inward flux.
Response to an acid load in preconditioning: pH recovery. The experiments measuring the effect of preconditioning after an acid load also support a significant effect of preconditioning on the activity of the Na-H exchanger. Potential mechanisms that "effectively" extrude protons from the myocyte include, in addition to the Na-H exchanger, the Cl --HCO3-exchanger and the C02-lactate cotransporter, although involvement of the Na'-dependent HCO3 transporter is also possible (14 Limitations. Whereas the current findings strongly support the hypothesis that ischemic preconditioning increases intracellular sodium concentration before ischemia and enhances proton efflux during ischemia, these observations must be interpreted within the limitations of the experimental design. First, the isolated heart model may not represent the in situ preconditioning effects observed in regional ischemia (1) . However, the beneficial effects of preconditioning on myocardial function and ischemic injury parallel those in other models, as do the effects on high energy phosphates and pH (4) . Thus, these similarities suggest that this model is representative of preconditioning. Second, while we have primarily addressed alterations in the Na-H exchanger and Na-K-2C1 cotransporter, other mechanisms limiting proton production (9, 41 ) or enhancing effective proton efflux (such as the Cl/HCO3 exchanger) may be altered by preconditioning, although the ammonium prepulse experiments with EIPA are consistent with previous results suggesting that a primary mechanism of proton efflux immediately after an acid load is Na-H exchange. Third, these data do not define the involvement of other cardioprotective mechanisms in preconditioning, such as ATP-sensitive K+ channels or adenosine receptor stimulation (5, 37) .
The technique of employing a shift reagent to measure intracellular sodium has inherent limitations. The low level of intracellular sodium under baseline conditions makes resolution and quantification of the intracellular resonance difficult and subject to greater error. However, the rise in Na, during ischemia improved resolution of the intracellular sodium resonance and made its measurement more reliable. While changes in the volume of the extracellular compartment that occur during ischemia and reperfusion may have changed the relative concentration of the shift reagent in the extracellular space, resulting in a change in chemical shift, the absence of significant changes in these chemical shifts suggests that concentration changes of the shift reagent in the extracellular space were minimal. Furthermore, because the cell membrane is impermeable to the shift reagent ( 19) , changes in extracellular concentration should not have altered the measurement of Nat. Finally, changes in lineshape of the intracellular resonances were observed and may have been due to spectral processing techniques or inherent changes in the intracellular sodium environment. The integration algorithms were therefore chosen without assumption of either a Lorentzian or Gaussian lineshape and should represent accurately the resonance intensity. However, potentially different intrinsic changes in the intracellular and extracellular compartments between the groups cannot be excluded as a factor in the measurement of Nat.
Conclusion. Ischemic preconditioning results in a rapid increase in Nai at the onset of global ischemia and a rapid decrease on reperfusion, consistent with activation of mechanisms that enhance sodium transport across the sarcolemma under these conditions. Greater acidification of preconditioned hearts in response to a NH4Cl prepulse is consistent with increased inward NH4' flux via the Na-K-2C1 cotransporter flux after preconditioning, whereas more rapid recovery from acidosis, which is inhibited by EIPA, indicates that proton efflux in preconditioned hearts is increased primarily by stimulation of Na-H exchange.
In combination with data showing reduced intracellular acidification during ischemia, these data support the postulate that a significant beneficial effect of ischemic preconditioning results from activation of the Na-H exchanger and/or Na-K-2C1 cotransporter before ischemia.
